# Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW)

> **NCT05401474** · NA · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 26 (estimated)

## Conditions studied

- High-Flow Nasal Cannula
- Oxygen Therapy
- Acute Respiratory Failure
- Respiratory Failure
- Lung Injury

## Interventions

- **DEVICE:** High Flow Nasal Cannula at 30L/min
- **DEVICE:** High Flow Nasal Cannula at 45L/min
- **DEVICE:** High Flow Nasal Cannula at 60L/min

## Key facts

- **NCT ID:** NCT05401474
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-18
- **Primary completion:** 2022-11-05
- **Final completion:** 2023-02-28
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05401474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05401474, "Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05401474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*